The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A safety trial of antibiotic fecal microbiota transplantation for esophageal and gastric cancer patients treated with immune checkpoint inhibitors (Biorich2 trial).
 
Yuri Yoshinami
No Relationships to Disclose
 
Hirokazu Shoji
Consulting or Advisory Role - Astellas Pharma
Research Funding - AbbVie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Elevation Oncology (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Takeda (Inst)
 
Natsuko Okita
No Relationships to Disclose
 
Hiroyuki Takamaru
No Relationships to Disclose
 
Toshiharu Hirose
Speakers' Bureau - Bristol Myers Squibb Foundation; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
 
Hiroshi Imazeki
No Relationships to Disclose
 
Shun Yamamoto
No Relationships to Disclose
 
Hidekazu Hirano
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Fujifilm; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Teijin Pharma
Research Funding - Amgen (Inst); BeiGene (Inst); Bristol-Myers Squibb Japan (Inst); Taiho Pharmaceutical (Inst)
 
Atsuo Takashima
Honoraria - Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Amgen - Local PI (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst)
 
Kazuki Tanaka
Employment - Metagen Therapeutics Inc.
 
Kana Ogawa
Employment - Metagen Therapeutics Inc.
 
Shohei Koyama
Consulting or Advisory Role - Kaken Pharmaceutical
Research Funding - Otsuka
 
Dai Ishikawa
Employment - Metagen Therapeutics Inc.
Leadership - Metagen Therapeutics Inc.
Stock and Other Ownership Interests - Metagen Therapeutics Inc.
Honoraria - Metagen Therapeutics Inc.
 
Ken Kato
Honoraria - BMS; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; BeiGene; MSD; Oncolys BioPharma; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Chugai Pharma (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)